Reply to: “correspondence about “Efficacy and safety of basiliximab”
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-03-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268122000217 |
| _version_ | 1818908513296973824 |
|---|---|
| author | Mohamed Hashim Ayman Alsebaey Amr Ragab Hossam Eldeen Soliman Imam Waked |
| author_facet | Mohamed Hashim Ayman Alsebaey Amr Ragab Hossam Eldeen Soliman Imam Waked |
| author_sort | Mohamed Hashim |
| collection | DOAJ |
| first_indexed | 2024-12-19T22:12:13Z |
| format | Article |
| id | doaj.art-fa23943efe034397b575930168c24cd6 |
| institution | Directory Open Access Journal |
| issn | 1665-2681 |
| language | English |
| last_indexed | 2024-12-19T22:12:13Z |
| publishDate | 2022-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Annals of Hepatology |
| spelling | doaj.art-fa23943efe034397b575930168c24cd62022-12-21T20:03:52ZengElsevierAnnals of Hepatology1665-26812022-03-01272100679Reply to: “correspondence about “Efficacy and safety of basiliximab”Mohamed Hashim0Ayman Alsebaey1Amr Ragab2Hossam Eldeen Soliman3Imam Waked4Department of Hepatology, National Liver Institute, Menoufiya University, Shebin Elkom, Egypt; Corresponding author.Department of Hepatology, National Liver Institute, Menoufiya University, Shebin Elkom, EgyptDepartment of Hepatology, National Liver Institute, Menoufiya University, Shebin Elkom, EgyptDepartment of Hepatobiliary and Pancreatic Surgery, National Liver Institute, Menoufiya University, Shebin Elkom, EgyptDepartment of Hepatology, National Liver Institute, Menoufiya University, Shebin Elkom, Egypthttp://www.sciencedirect.com/science/article/pii/S1665268122000217 |
| spellingShingle | Mohamed Hashim Ayman Alsebaey Amr Ragab Hossam Eldeen Soliman Imam Waked Reply to: “correspondence about “Efficacy and safety of basiliximab” Annals of Hepatology |
| title | Reply to: “correspondence about “Efficacy and safety of basiliximab” |
| title_full | Reply to: “correspondence about “Efficacy and safety of basiliximab” |
| title_fullStr | Reply to: “correspondence about “Efficacy and safety of basiliximab” |
| title_full_unstemmed | Reply to: “correspondence about “Efficacy and safety of basiliximab” |
| title_short | Reply to: “correspondence about “Efficacy and safety of basiliximab” |
| title_sort | reply to correspondence about efficacy and safety of basiliximab |
| url | http://www.sciencedirect.com/science/article/pii/S1665268122000217 |
| work_keys_str_mv | AT mohamedhashim replytocorrespondenceaboutefficacyandsafetyofbasiliximab AT aymanalsebaey replytocorrespondenceaboutefficacyandsafetyofbasiliximab AT amrragab replytocorrespondenceaboutefficacyandsafetyofbasiliximab AT hossameldeensoliman replytocorrespondenceaboutefficacyandsafetyofbasiliximab AT imamwaked replytocorrespondenceaboutefficacyandsafetyofbasiliximab |